Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	21,023	26,274	8,412	8,351	5,720	5,368
Market Cap Growth	95.51%	212.32%	0.74%	46.00%	6.56%	-30.92%
Enterprise Value	24,552	34,991	9,289	9,299	9,130	7,738
Last Close Price	36.50	45.60	32.84	32.60	22.33	20.95
PE Ratio	59.64	86.66	-	3.80	66.05	-
PS Ratio	3.92	4.90	1.97	1.20	1.35	4.79
PB Ratio	4.36	5.44	1.77	0.96	0.83	0.73
P/TBV Ratio	6.60	8.25	-	1.41	1.71	1.19
P/FCF Ratio	59.20	73.98	-	5.70	4.48	-
P/OCF Ratio	16.35	20.44	15.79	4.53	2.98	-
EV/Sales Ratio	4.58	6.53	2.17	1.34	2.16	6.90
EV/EBITDA Ratio	19.13	28.61	11.94	2.66	11.68	-
EV/EBIT Ratio	31.92	45.49	24.33	3.03	25.02	-
EV/FCF Ratio	69.13	98.53	-	6.35	7.15	-
Debt / Equity Ratio	1.08	1.08	1.03	0.33	0.63	0.53
Debt / EBITDA Ratio	4.06	4.06	5.95	0.82	5.46	-
Debt / FCF Ratio	14.66	14.66	-	1.96	3.38	-
Net Debt / Equity Ratio	0.73	0.73	0.70	0.12	0.43	0.34
Net Debt / EBITDA Ratio	2.89	2.89	4.30	0.30	3.77	-9.98
Net Debt / FCF Ratio	9.96	9.96	-5.59	0.70	2.31	-2.02
Asset Turnover	0.40	0.40	0.33	0.51	0.33	0.09
Inventory Turnover	1.49	1.49	1.68	3.62	3.02	1.31
Quick Ratio	0.56	0.56	0.70	0.87	0.46	1.36
Current Ratio	0.77	0.77	1.03	1.40	1.01	1.66
Return on Equity (ROE)	6.13%	6.13%	0.40%	26.50%	0.81%	-10.57%
Return on Assets (ROA)	3.61%	3.61%	1.82%	14.16%	1.80%	-2.85%
Return on Invested Capital (ROIC)	5.65%	5.62%	0.77%	27.75%	3.85%	-6.47%
Return on Capital Employed (ROCE)	11.60%	11.60%	5.00%	33.20%	4.60%	-4.90%
Earnings Yield	1.44%	1.15%	-2.62%	26.29%	1.51%	-13.44%
FCF Yield	1.69%	1.35%	-7.10%	17.54%	22.33%	-23.30%
Payout Ratio	214.52%	214.52%	-	-	-	-
Buyback Yield / Dilution	-13.00%	-13.00%	-90.10%	-	-	20.42%
Total Shareholder Return	1.96%	-13.00%	-90.10%	-	-	20.42%